XBIO Stock 12 Month Analyst Forecast
Eps Overview
Growth Next 5yrs
N/A
Last Quarter
- $0.22
Past Year
- $2.05
Growth Past 5yrs
47.32%
Next Quarter
-
Estimate Next Year
$77.30
Consensus Rating
Loading...
Consensus Price Target
Highest Price Target
N/A
0% Upside
Mean Price Target
N/A
0% Upside
Lowest Price Target
N/A
0% Upside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Last Updated On Apr 10, 2025
Actual EPS vs Estimated EPS
XBIO Earnings Per Share (EPS) History
According to financial reports, XBIO (NYSE: XBIO) reported an actual EPS of $-0.22 for the quarter ending on Mar 12, 2026, compared to an estimated $-0.52, resulting in a -57.69% surprise. In the prior quarter (Nov 12, 2025), XBIO recorded an actual EPS of $-0.33 with a -32.65% surprise. See XBIO's full earnings history.
Earnings History
EPS Surprise Factor Analysis
XBIO has experienced notable EPS surprises, with the latest quarter ending Mar 12, 2026 showing a -57.69% miss. Previously, the quarter ending Nov 12, 2025 recorded a -32.65% miss. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Mar 12, 2026 | -0.22 | -0.52 | -57.69% |
| Nov 12, 2025 | -0.33 | -0.49 | -32.65% |
| Aug 12, 2025 | -0.45 | -0.64 | -29.69% |
| May 13, 2025 | -0.59 | -0.72 | -18.06% |
| Nov 12, 2024 | -0.28 | -0.14 | +100.00% |
| Aug 13, 2024 | -0.83 | -0.83 | 0 |
Frequently Asked Questions
Is XBIO stock getting favorable reviews from Wall Street analysts?
Brokerage firms have given XBIO stock an average recommendation of
N/A. 0 analysts have given their ratings
to XBIO out of which
0 analysts have given strong buy call,
0 analysts have given buy call,
0 analysts rate it hold,
0 analysts advocate strong sell call, and
0 analysts has given sell rating. The average target price of
- gives the stock implied downside
of roughly 0% over the next year or so.
What have analysts suggested for XBIO highest price target?
Analysts suggest XBIO's stock price would rise to a high of -.
What is the lowest price target analysts expect for XBIO over the next year?
Within the next 12 months, analysts predict the XBIO stock price could move to -.
What is the average target price for XBIO?
XBIO stock has an average analyst estimate of -.
At its current price, how far is XBIO from its average target price?
XBIO shares are currently trading 0% below this price target.
What were XBIO’s actual earnings per share for the recent quarter?
Its quarterly earnings per share (EPS) came in at - $0.22 versus consensus estimates of - $0.52, and above the comparable year-ago quarter’s EPS of - $0.28.
What are the current estimates for quarterly and annual earnings per share?
XBIO's forecasts by analysts estimating quarterly EPS at - and $77.30 for the whole year.
What has XBIO's growth been in the past five years and what is expected in the next five years?
The analysts have projected N/A EPS growth for XBIO in the next five years, compared to growth rates of 47.32% in the past five years.